Answer:
The Biologics Discovery team at BioDuro has more than 40 scientists and is led by a pharma- and biotech-experienced team with more than 100 years of combined biologics experience. The new service offerings, focused on antibody discovery and cellular therapies, include:
Single B cell and next-generation animal-based Ab discovery. Increase efficiency of clone retrieval, resulting in higher quality antibody ‘hits’ in less time.
AI powered synthetic Ab technology. Achieve higher efficiency, better developability and overcome the limitation of animal immune systems compared to traditional methods
